| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/24/2014 | CN103432096B 由卡拉胶和柠檬酸钾凝胶的羟丙甲纤维素肠溶空心胶囊 By carrageenan and potassium citrate gel hypromellose enteric hollow capsules |
| 12/24/2014 | CN103405756B 药物组合物复方消化酶胶囊(ii)及其制备方法 The pharmaceutical composition of compound digestive enzyme capsules (ii) its preparation method |
| 12/24/2014 | CN103393610B 一种脂肪胺聚合物盐快速崩解制剂 A fatty amine polymer salt rapidly disintegrating formulation |
| 12/24/2014 | CN103304417B 一种双亲性共聚物改性壳聚糖复合物的制备及应用 Preparation and application of an amphiphilic copolymer modified chitosan complexes |
| 12/24/2014 | CN103301204B 一种复方连翘-柴胡油纳米乳制剂以及制备方法 A COMPOUND Forsythia - Bupleurum oil nanoemulsion formulation and preparation |
| 12/24/2014 | CN103301120B 复方氨基酸注射液的制备方法 Compound amino acid injection preparation |
| 12/24/2014 | CN103251558B 高载药量的具有组合治疗效果的多功能纳米药物的制备 Preparation of high drug loading effect of combination therapy with a multifunctional nano-drugs |
| 12/24/2014 | CN103191125B 一种缬沙坦氢氯噻嗪片剂及其制备方法 One kind of hydrochlorothiazide tablets and preparation method valsartan |
| 12/24/2014 | CN103191124B 一种缬沙坦氢氯噻嗪胶囊剂及其制备方法 One kind of hydrochlorothiazide capsules and preparation method valsartan |
| 12/24/2014 | CN103127009B 一种红花黄色素舌下片及其制备方法和应用 One kind of safflower yellow sublingual tablets and preparation method and application |
| 12/24/2014 | CN103083680B 聚乙二醇-氨基酸寡肽-依诺替康药物结合物及其药物组合物 Polyethylene glycol - an amino acid oligopeptide - enoxaparin irinotecan drug conjugates and pharmaceutical compositions thereof |
| 12/24/2014 | CN102973536B 自组装药物囊泡及其构建方法 Drug vesicle self-assembly and construction method |
| 12/24/2014 | CN102940607B 一种氨苄西林舒巴坦钠药物组合物注射剂及其制备方法 One kind of pharmaceutical compositions ampicillin sulbactam sodium injection and its preparation method |
| 12/24/2014 | CN102939078B 含有维生素d类似物和皮质类固醇的药用喷雾剂组合物 Pharmaceutical compositions containing vitamin d spray analogues and corticosteroids |
| 12/24/2014 | CN102872234B 畜禽用清开灵柴胡口腔崩解片及其制备方法 Livestock Qingkailing Chaihu orally disintegrating tablets and preparation method |
| 12/24/2014 | CN102784600B 一种叶黄素微胶囊的制备方法 One kind of lutein microcapsules prepared |
| 12/24/2014 | CN102762647B 交联氧化透明质酸作为眼球玻璃体之替代物 Cross-linked hyaluronic acid oxidation as a substitute for the vitreous of the eye |
| 12/24/2014 | CN102743355B 含有阿片类镇痛剂的抗篡改口服药物剂型 Anti containing opioid analgesic oral dosage form of tampering |
| 12/24/2014 | CN102727452B 一种含右佐匹克隆的颗粒及其制备方法 An eszopiclone containing particles and preparation method |
| 12/24/2014 | CN102711788B 使用组织特异性模拟肽配体的靶向递送 The use of tissue-specific targeted delivery analog peptide ligands |
| 12/24/2014 | CN102470165B 包含胰岛素、烟酰胺和氨基酸的制剂 Formulations containing insulin, nicotinamide and amino acids |
| 12/24/2014 | CN102451463B 眼镜蛇镇痛多肽透皮制剂 Cobra analgesic peptide transdermal preparations |
| 12/24/2014 | CN102429876B 利拉鲁肽缓释微球制剂及其制备方法 Liraglutide release microsphere formulation and preparation method |
| 12/24/2014 | CN102380359B 一种尺寸均一的分子印迹聚合物纳微球制备方法及应用 One size molecularly imprinted polymer microspheres Carolina uniform preparation method and application |
| 12/24/2014 | CN102370978B 温度敏感性乙型肝炎疫苗 Temperature sensitivity of hepatitis B vaccine |
| 12/24/2014 | CN102342930B 硝酸芬替康唑药物组合物 Finland nitrate pharmaceutical compositions for itraconazole |
| 12/24/2014 | CN102240040B 用于减少心血管疾病风险的油体缔合蛋白质的组合物和方法及其用途 Used in the compositions and methods for reducing the risk of cardiovascular disease associated oil body protein and use thereof |
| 12/24/2014 | CN102100907B 口服药理活性剂组合物 Oral pharmacologically active agent composition |
| 12/24/2014 | CN101903017B 具有增强的脉冲活性物质释放的包衣的药物或营养制剂 Pharmaceutical or nutritional formulation having enhanced pulse release coat of the active substance |
| 12/23/2014 | US8916696 Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use |
| 12/23/2014 | US8916693 Monoconjugated chitosans as delivery agents for small interfering nucleic acids |
| 12/23/2014 | US8916692 Reagent system and method for modifying the luminescence of lanthanide(III) macrocyclic complexes |
| 12/23/2014 | US8916685 Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof |
| 12/23/2014 | US8916683 Nanostructured physically-associating hydrogels for injectable, responsive, and tough biomaterials |
| 12/23/2014 | US8916616 Multi-functional polymeric materials and their uses |
| 12/23/2014 | US8916613 Synergistic insecticidal mixtures |
| 12/23/2014 | US8916606 Therapeutic compositions and methods for targeted delivery of active agents |
| 12/23/2014 | US8916603 Methods for treatment with bucindolol based on genetic targeting |
| 12/23/2014 | US8916583 Therapeutic compositions for intranasal administration of zolpidem |
| 12/23/2014 | US8916545 Pharmaceutical compositions comprising POH derivatives |
| 12/23/2014 | US8916518 Coupling proteins to a modified polysaccharide |
| 12/23/2014 | US8916206 Nanoparticles containing water-soluble non-peptide low-molecular weight drug |
| 12/23/2014 | US8916203 Stable formulations for lyophilizing therapeutic particles |
| 12/23/2014 | US8916198 Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents |
| 12/23/2014 | US8916193 Rifaximin complexes |
| 12/23/2014 | US8916191 Device for transdermal administration of drugs including acrylic polymers |
| 12/23/2014 | US8916190 Method of inducing hemostasis in a wound |
| 12/23/2014 | US8916170 Methods of producing antibodies against morphine-heroine |
| 12/23/2014 | US8916167 Treatment and diagnosis of macrophage mediated disease |
| 12/23/2014 | US8916159 Selenocysteine mediated hybrid antibody molecules |
| 12/23/2014 | US8916158 Formulation of human antibodies for treating TNF-α associated disorders |
| 12/23/2014 | US8916157 Formulation of human antibodies for treating TNF-α associated disorders |
| 12/23/2014 | US8916150 Compositions and methods for enhancing metal ion dependent drug therapies |
| 12/23/2014 | US8916145 Use of Bifidobacterium longum for the prevention and treatment of inflammation |
| 12/23/2014 | US8916144 Proangiogenic compositions, method for preparing same, and uses thereof |
| 12/23/2014 | US8916143 Polymer compositions of dihydroxyacetone and uses thereof |
| 12/23/2014 | US8916134 Metal nanocomposite, preparation method and use thereof |
| 12/23/2014 | US8916131 Radiopharmaceutical composition |
| 12/18/2014 | US20140371432 Novel oligonucleotide conjugates and use thereof |
| 12/18/2014 | US20140371401 Pamam, spacer molecule and cafestol polymers |
| 12/18/2014 | US20140371333 Lecithin-organogelling agent |
| 12/18/2014 | US20140371329 Buffered Oxygen Therapeutic |
| 12/18/2014 | US20140371323 Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
| 12/18/2014 | US20140371321 Novel process for concentrating spilanthol and/or isomers and/or homologues thereof |
| 12/18/2014 | US20140371320 Compositions and methods for stimulating hair growth |
| 12/18/2014 | US20140371318 Orally-disintegrating formulations of flurbiprofen |
| 12/18/2014 | US20140371317 Silicone Resin Emulsions |
| 12/18/2014 | US20140371315 Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids |
| 12/18/2014 | US20140371309 Ophthalmic solution |
| 12/18/2014 | US20140371308 Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| 12/18/2014 | US20140371305 Mupirocin Antibiotic Composition |
| 12/18/2014 | US20140371293 Amine Cationic Lipids and Uses Thereof |
| 12/18/2014 | US20140371292 Method for the controlled intracellular delivery of nucleic acids |
| 12/18/2014 | US20140371282 Controlled release pharmaceutical compositions with improved bioavailabililty |
| 12/18/2014 | US20140371258 Water-Soluble Polymer Conjugates of Topotecan |
| 12/18/2014 | US20140371257 Pharmaceutical Formulation Containing Gelling Agent |
| 12/18/2014 | US20140371191 Oromucosal Liquid Estradiol Compositions |
| 12/18/2014 | US20140371187 Semi-solid delivery vehicle and pharmaceutical compositions |
| 12/18/2014 | US20140371169 Aqueous iron carbohydrate complexes, their production and medicaments containing them |
| 12/18/2014 | US20140371150 Peptides targeting receptor activator of nuclear factor - kappa b (rank) and their applications |
| 12/18/2014 | US20140371148 Peptide-peptidase inhibitor conjugates and methods of using same |
| 12/18/2014 | US20140371145 Scaffold for vascular endothelial cell migration |
| 12/18/2014 | US20140371139 Preparations containing amorphous emodepside |
| 12/18/2014 | US20140371137 Preparation of pna-6-aminoglucosamine conjugates as antiviral agents |
| 12/18/2014 | US20140371136 Growth hormone polypeptides and methods of making and using same |
| 12/18/2014 | US20140370500 Nonviral targeted nanoparticle system for gene transfer and drug delivery |
| 12/18/2014 | US20140370109 Stabilized Granules Containing Glyceryl Trinitrate |
| 12/18/2014 | US20140370104 Pharmaceutical formulation and method for treating acid caused gastrointestinal disorders |
| 12/18/2014 | US20140370103 Non-immunogenic delivery vehicle for betta-, gamma-, and delta-tocopherols and methods of using and making same |
| 12/18/2014 | US20140370094 Silk-based scaffold platform for engineering tissue constructs |
| 12/18/2014 | US20140370086 Sublingual immunotherapy with reduced oral itchiness |
| 12/18/2014 | US20140370081 Stable crystal modifications of dotap chloride |
| 12/18/2014 | US20140370049 Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxide |
| 12/18/2014 | US20140370046 Beta-glucan compounds, compositions, and methods |
| 12/18/2014 | US20140370042 Stabilized Antiviral Fusion Helices |
| 12/18/2014 | US20140370037 Dll3 modulators and methods of use |
| 12/18/2014 | US20140370035 Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy |
| 12/18/2014 | US20140370016 Sparc binding scfvs |
| 12/18/2014 | US20140370000 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph |
| 12/18/2014 | US20140369997 Pharmaceutical composition for a foaming eye drop |